Pipeline cherrypicking deal yields lucrative return

Article Abstract:

Elelixis presented phase I clinical trial data for three new kinase inhibitors at the 2006 American Society of Clinical Oncology annual meeting held in Atlanta, Georgia June 2-3, 2006. The compounds are included in a licensing and development deal with GlaxoSmithKline (GSK) that gives the pharma partner an option on 3 of 12 specified products in development.

Alliances, partnerships, Enzyme Inhibitors, United Kingdom, Research, Pharmaceutical industry, Clinical trials, GlaxoSmithKline PLC, Research agreements

---

A peptide carrier for the delivery of biologically active proteins into mammalian cells

Article Abstract:

Researchers in France have designed a 21-residue peptide carrier drug delivery system that can transport large molecule proteins, which would otherwise be difficult to permeate cell walls.

France, Liposome Drug Delivery Systems, Liposomes

---

Malaria: together with major international initiatives, companies are launching an offense against the world's most deadly parasitic disease

Article Abstract:

Between 300 and 500 million people contract malaria every year, and about 3 million die, most of them children under five years of age. Malaria kills 3,000 children a day under five.

World, Antimalarial & Antifungal Preps, Brief Article

Similar abstracts:

• Abstracts: Option to acquire or divest a joint venture. How much do your co-opetitors' capabilities matter in the face of technological change?
• Abstracts: Video PR pros take more realistic view of the 'Net. Travel writers go one-on-one with PR pros at media showcase
• Abstracts: Norm violations and the role of marketplace comparisons in positioning brands. The Influence of Cause-Related Marketing on Consumer Choice: Does One Good Turn Deserve Another?
• Abstracts: Detecting estrogens in food and the environment. Bioassay of prostate-specific antigen (PSA) using microcantilevers
• Abstracts: On the verge of change. An accounting system in change. The devil is in the detail

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.